DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Nabiximols

Nabiximols

  • The Role of Organic Small Molecules in Pain Management

    The Role of Organic Small Molecules in Pain Management

  • Pharmacy and Poisons (Third and Fourth Schedule Amendment) Order 2017

    Pharmacy and Poisons (Third and Fourth Schedule Amendment) Order 2017

  • Urine Drug Screening (UDS)

    Urine Drug Screening (UDS)

  • D30c5a005c7b549217479d4cbb

    D30c5a005c7b549217479d4cbb

  • Nabiximols for the Treatment of Cannabis Dependence a Randomized Clinical Trial

    Nabiximols for the Treatment of Cannabis Dependence a Randomized Clinical Trial

  • Neuropathic Pain in Serious Medical Illness

    Neuropathic Pain in Serious Medical Illness

  • Icrs2016 Programme

    Icrs2016 Programme

  • (Cannabimimetics) in Serum, Hair, and Urine by Rapid and Sensitive HPLC Tandem Mass Spectrometry Screenings: Overview and Experience from Routine Testing

    (Cannabimimetics) in Serum, Hair, and Urine by Rapid and Sensitive HPLC Tandem Mass Spectrometry Screenings: Overview and Experience from Routine Testing

  • Abuse and Dependence Potential of Cannabis Sativa and Nabiximols

    Abuse and Dependence Potential of Cannabis Sativa and Nabiximols

  • Safety and Efficacy of Nabiximols in People with Multiple Sclerosis–Associated Joanne Wagner2 | Jerry S

    Safety and Efficacy of Nabiximols in People with Multiple Sclerosis–Associated Joanne Wagner2 | Jerry S

  • Delegates' Interim Decisions and Reasons for Decisions

    Delegates' Interim Decisions and Reasons for Decisions

  • Drugs of Choice 2019

    Drugs of Choice 2019

  • Marijuana Legalization

    Marijuana Legalization

  • Scheduling: Delegates' Reasons for Final Decisions

    Scheduling: Delegates' Reasons for Final Decisions

  • (RCT) of Cannabinoid Replacement Therapy (Nabiximols) for the Management of Treatment-Resistant Cannabis Dependent Patients: a Study Protocol Anjali K

    (RCT) of Cannabinoid Replacement Therapy (Nabiximols) for the Management of Treatment-Resistant Cannabis Dependent Patients: a Study Protocol Anjali K

  • 5.01.32 Medical Cannabis for the Treatment of Pain and Spasticity

    5.01.32 Medical Cannabis for the Treatment of Pain and Spasticity

  • GW Pharmaceuticals and U.S. Subsidiary Greenwich Biosciences to Present Data at the 2021 American Academy of Neurology (AAN) Annual Meeting

    GW Pharmaceuticals and U.S. Subsidiary Greenwich Biosciences to Present Data at the 2021 American Academy of Neurology (AAN) Annual Meeting

  • NSW Young Lawyers Criminal Law Committee

    NSW Young Lawyers Criminal Law Committee

Top View
  • (12) Patent Application Publication (10) Pub. No.: US 2016/0256411 A1 AUNG-DIN (43) Pub
  • Nabiximols As an Agonist Replacement Therapy During Cannabis Withdrawal a Randomized Clinical Trial
  • Appendix 1: Literature Provided by Petition Applicant
  • Australian Public Assessment Report for Nabiximols
  • Medical Cannabis for Non-Cancer Pain: a Systematic Review
  • The Endocannabinoid System and Cannabidiol's Promise for The
  • Misuse of Drugs Amendment Regulations 2017
  • Reasons for Scheduling Delegate's Final Decisions for the ACMS, March
  • Update on Marijuana
  • Cannabinoids in Glioblastoma Multiforme—Hype Or Hope?
  • (Nabiximols) for the Management of Treatment-Resistant Cannabis Dependent Patients: Methods and Baseline Data
  • A Potential Target for the Treatment of Various Diseases
  • Guidance for the Use of Medicinal Cannabis in the Treatment of Chronic
  • Endocannabinoidome and Its Role in Neurological Disorders-A Comprehensive Update of Existing Literature Literature
  • Challenges and Opportunities in Preclinical Research of Synthetic Cannabinoids for Pain Therapy
  • Molecular Mechanism of Cannabinoids in Cancer Progression
  • Adult Cancer Pain, Version 3.2019
  • A Guide to Targeting the Endocannabinoid System in Drug Design


© 2024 Docslib.org    Feedback